Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00267982 · ClinicalTrials.gov registry record
Radiofrequency Ablation of Ectopic Atrial Tachycardia
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 25
- Enrollment target
NCT00267982: Clinical Trial study, sponsored by Children's Healthcare of Atlanta.
NCT00267982 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00267982 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
A retrospective chart review will be performed on 50 patients who received RFA for the treatment of EAT between August 1992 and August 2003 at Children's Healthcare of Atlanta. The use of the CARTO/Biosense catheter has improved outcomes with decreased radiation exposure to patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 1992-08 |
| Est. Completion | 2008-02 |
Why NCT00267982 stopped before completion
NCT00267982 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00267982 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00267982 about?
NCT00267982 is a clinical study titled "Radiofrequency Ablation of Ectopic Atrial Tachycardia". A retrospective chart review will be performed on 50 patients who received RFA for the treatment of EAT between August 1992 and August 2003 at Children's Healthcare of Atlanta. The use of the CARTO/Biosense catheter has improved outcomes with decreased radiation exposure to patients.
What is the current status of trial NCT00267982?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 1992-08. Estimated completion is 2008-02.
Who is sponsoring clinical trial NCT00267982?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia